title: Biogenerics: Europe takes another step forward while the FDA dives for cover.
authors.forename: Paul
authors.initials: P
authors.lastname: Chamberlain
mesh_terms: D001709:Biotechnology / Q000331:legislation & jurisprudence*; D005062:European Union; D011057:Politics; D011994:Recombinant Proteins / Q000592:standards*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D011994:Recombinant Proteins